TREM2 expression is increased in AD, which may be a compensatory mechanism, as AD-associated TREM2 mutations are partial loss of function and can affect receptor binding of TREM2 to its associated ligands [73, 74]. The gene discussed is TREM2; the disease is Alzheimer disease.